STAT

My work-life balance is tilting toward work. I’m trying to tilt it back

It’s easy to feel guilty if weekends often involve more sunglasses than safety glasses. But taking breaks will make me a better scientist in the long run.

“What’s hot for the weekend?”

For graduate students like me, this is a loaded question.

It’s asking, however friendly the intent, “What will you prioritize this weekend? Churning out data, or working on your tan?”

The bread and butter of biomedical research is publishing research papers to get grants to publish more research papers to get more grants. This means hundreds, if not thousands, of hours of work, of timed experiments that don’t skip weekends, and of model organisms that need to be fed and looked after, even if it’s Friday night.

It’s competitive, meaning 10-

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks